newsfilter
← Latest News
PR Newswire·

Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients...